BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 18454575)

  • 1. Strategies for successfully managing the anemia of chronic kidney disease in the long-term care setting.
    Germain MJ
    Consult Pharm; 2008 Mar; 23 Suppl A():11-7. PubMed ID: 18454575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triumph and tragedy: anemia management in chronic kidney disease.
    Novak JE; Szczech LA
    Curr Opin Nephrol Hypertens; 2008 Nov; 17(6):580-8. PubMed ID: 18941350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Putting it into practice: strategizing a successful anemia management protocol in the long-term care setting.
    Saffel D
    Consult Pharm; 2008 Mar; 23 Suppl A():18-23. PubMed ID: 18454576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood transfusion use in non-dialysis-dependent chronic kidney disease patients aged 65 years and older.
    Ibrahim HN; Ishani A; Guo H; Gilbertson DT
    Nephrol Dial Transplant; 2009 Oct; 24(10):3138-43. PubMed ID: 19451656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion burden among patients with chronic kidney disease and anemia.
    Lawler EV; Bradbury BD; Fonda JR; Gaziano JM; Gagnon DR
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):667-72. PubMed ID: 20299366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meeting new challenges in the management of anemia of chronic kidney disease through collaborative care with pharmacists.
    Bacchus S; O'Mara N; Manley H; Fishbane S
    Ann Pharmacother; 2009 Nov; 43(11):1857-66. PubMed ID: 19826095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron therapy in chronic kidney disease: current controversies.
    Kovesdy CP; Kalantar-Zadeh K
    J Ren Care; 2009 Dec; 35 Suppl 2():14-24. PubMed ID: 19891681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug utilization and cost for erythropoiesis-stimulating agents in a long-term care resident population with chronic kidney disease.
    Lafeuille MH; Bailey RA; Vekeman F; Kilpatrick BS; Senbetta M; Piech CT; Lefebvre P
    Consult Pharm; 2010 Aug; 25(8):493-500. PubMed ID: 20736158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Undertreatment of anemia in patients with chronic kidney disease in the United States: analysis of national outpatient survey data.
    Rasu RS; Manley HJ; Crawford T; Balkrishnan R
    Clin Ther; 2007 Jul; 29(7):1524-34. PubMed ID: 17825703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualizing decision-making--resurrecting the doctor-patient relationship in the anemia debate.
    Agarwal R
    Clin J Am Soc Nephrol; 2010 Jul; 5(7):1340-6. PubMed ID: 20448071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Regarding the optimal hemoglobin target range in renal anemia].
    Maurin N
    Med Klin (Munich); 2008 Sep; 103(9):633-7. PubMed ID: 18813886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anemia in renal disease: diagnosis and management.
    Lankhorst CE; Wish JB
    Blood Rev; 2010 Jan; 24(1):39-47. PubMed ID: 19833421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of anemia in chronic kidney disease: understandings in 2006.
    Levin A
    Curr Opin Nephrol Hypertens; 2007 May; 16(3):267-71. PubMed ID: 17420672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anemia in the long-term care setting: routine screening and differential diagnosis.
    Dharmarajan TS
    Consult Pharm; 2008 Mar; 23 Suppl A():5-10. PubMed ID: 18454574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The benefits of IV iron therapy in treating anemia in patients with renal disease and comorbid cardiovascular disease.
    Singh AK; Hertello P
    Nephrol Nurs J; 2005; 32(2):199-206; quiz 207-8. PubMed ID: 15889804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transfusion requirements in chronic kidney disease].
    Frimat L
    Transfus Clin Biol; 2008 Nov; 15(5):214-6. PubMed ID: 18938100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From anemia trials to clinical practice: understanding the risks and benefits when setting goals for therapy.
    Coyne DW
    Semin Dial; 2008; 21(3):212-6. PubMed ID: 18363603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintaining control over haemoglobin levels: optimizing the management of anaemia in chronic kidney disease.
    Bárány P; Müller HJ
    Nephrol Dial Transplant; 2007 Jun; 22 Suppl 4():iv10-iv18. PubMed ID: 17526545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing anemia management in hospitalized patients with end-stage renal disease.
    Heung M; Mueller BA; Segal JH
    Ann Pharmacother; 2009 Feb; 43(2):276-82. PubMed ID: 19141655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative management of anemia: limits of blood transfusion and alternatives to it.
    Kumar A
    Cleve Clin J Med; 2009 Nov; 76 Suppl 4():S112-8. PubMed ID: 19880828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.